Co-founder and Chief Executive Officer, Alamar Biosciences
Appears in 1 story
Leading company through IPO and commercial launch
Alamar Biosciences raised $191 million in its initial public offering on April 17, 2026 — nearly double the $100 million it originally planned — after investor demand exceeded available shares by more than tenfold. The Fremont, California company develops technology that detects proteins in blood at concentrations so low that conventional tests miss them entirely, potentially catching diseases years earlier than current methods allow. The company reported $74 million in revenue for fiscal year 2025, giving public investors a baseline for tracking commercial growth against the IPO's lofty expectations.
Updated 2 hours ago
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
